A prospective, multi-centre trial of PSMA-PET compared to FDG-PET for staging of newly diagnosed high risk prostate cancer.

EJNMMI Res · 2025 · PMC12290150 · PMID 40705116

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Participants who did not achieve PSA remission had a higher proportion of stage ≥ 3 tumours on MRI (86% vs 38%, p = 0.04) and ISUP Grade Group 5 (100% vs 58%, p = 0.07) but did not reach statistical significance (Supplementary Table 3 ; Supplementary Fig. 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.